P-glycoprotein induction by breast milk attenuates intestinal inflammation in experimental necrotizing enterocolitis

Laboratory Investigation

Volumn 91, Issue 11, 2011, Pages 1668-1679

  Guner, Yigit S ^a,b   Franklin, Ashanti L ^a   Chokshi, Nikunj K ^a,b   Castle, Shannon L ^a,b   Pontarelli, Elizabeth ^a,b   Wang, Jin ^a   Wang, Larry ^a,b   Prasadarao, Nemani V ^a,b   Upperman, Jeffrey S ^a,b   Grishin, Anatoly V ^a,b   Ford, Henri R ^a,b  

^a CHILDREN S HOSPITAL LOS ANGELES   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

bacteria; breast milk; intestinal epithelium; necrotizing enterocolitis; P glycoprotein

Indexed keywords

EPIDERMAL GROWTH FACTOR; GLYCOPROTEIN P;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; ARTIFICIAL MILK; BREAST FEEDING; BREAST MILK; CELL LINE; DISEASE PREDISPOSITION; ENTERITIS; ENTEROBACTER SAKAZAKII; EPITHELIUM CELL; FEMALE; GENE; HYPOTHERMIA; HYPOXIA; IN VITRO STUDY; INTESTINE CELL; INTESTINE INJURY; MULTIPLE DRUG RESISTANCE 1A GENE; NECROTIZING ENTEROCOLITIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; RAT; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; ANIMALS, NEWBORN; BLOTTING, WESTERN; CRONOBACTER SAKAZAKII; DNA PRIMERS; ENTEROBACTERIACEAE INFECTIONS; ENTEROCOLITIS, NECROTIZING; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; INFLAMMATION; INTESTINE, SMALL; MICE; MICE, KNOCKOUT; MILK; MILK SUBSTITUTES; P-GLYCOPROTEINS; PLASMIDS; RATS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STATISTICS, NONPARAMETRIC; TRANSFECTION;

EID: 80155151902     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2011.113     Document Type: Article

References (82)

1. Guthrie SO, Gordon PV, Thomas V, et al. Necrotizing enterocolitis among neonates in the United States. J Perinatol 2003;23:278-285. (Pubitemid 36764115)
2. Hammerman C, Bin-Nun A, Kaplan M. Germ warfare: probiotics in defense of the premature gut. Clin Perinatol 2004;31:489-500. (Pubitemid 39119481)
3. Morowitz MJ, Poroyko V, Caplan M, et al. Redefining the role of intestinal microbes in the pathogenesis of necrotizing enterocolitis. Pediatrics; 125:777-785.
4. Patole S. Prevention and treatment of necrotising enterocolitis in preterm neonates. Early Hum Dev 2007;83:635-642. (Pubitemid 47539741)
5. Hall NJ, Eaton S, Peters MJ, et al. Mild controlled hypothermia in preterm neonates with advanced necrotizing enterocolitis. Pediatrics 2010;125:e300-e308.
6. Hsueh W, Caplan MS, Qu XW, et al. Neonatal necrotizing enterocolitis: clinical considerations and pathogenetic concepts. Pediatr Dev Pathol 2003;6:6-23. (Pubitemid 36323623)
7. Nowicki PT. Ischemia and necrotizing enterocolitis: where, when, and how. Semin Pediatr Surg 2005;14:152-158. (Pubitemid 41111601)
8. Powell RW, Dyess DL, Collins JN, et al. Regional blood flow response to hypothermia in premature, newborn, and neonatal piglets. J Pediatr Surg 1999;34:193-198. (Pubitemid 29047279)
9. Sase M, Lee JJ, Ross MG, Buchmiller-Crair TL. Effect of hypoxia on fetal rabbit gastrointestinal motility. J Surg Res 2001;99:347-351. (Pubitemid 32703458)
10. Guner YS, Friedlich P, Wee CP, et al. State-based analysis of necrotizing enterocolitis outcomes. J Surg Res 2009;157:21-29.
11. Salzman AL, Menconi MJ, Unno N, et al. Nitric oxide dilates tight junctions and depletes ATP in cultured Caco-2BBe intestinal epithelial monolayers. Am J Physiol 1995;268(2 Part 1):G361-G373.
12. Anand RJ, Leaphart CL, Mollen KP, et al. The role of the intestinal barrier in the pathogenesis of necrotizing enterocolitis. Shock 2007;27:124-133. (Pubitemid 46105827)
13. Frost BL, Jilling T, Caplan MS. The importance of pro-inflammatory signaling in neonatal necrotizing enterocolitis. Semin Perinatol 2008;32:100-106. (Pubitemid 351381163)
14. Neu J, Chen M, Beierle E. Intestinal innate immunity: how does it relate to the pathogenesis of necrotizing enterocolitis. Semin Pediatr Surg 2005;14:137-144. (Pubitemid 41111599)
15. Neu J, Mshvildadze M, Mai V. A roadmap for understanding and preventing necrotizing enterocolitis. Curr Gastroenterol Rep 2008;10:450-457.
16. Srinivasan PS, Brandler MD, D'Souza A. Necrotizing enterocolitis. Clin Perinatol 2008;35:251-272, x. (Pubitemid 351246701)
17. Boyd CA, Quigley MA, Brocklehurst P. Donor breast milk vs infant formula for preterm infants: systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed 2007;92:F169-F175. (Pubitemid 46698111)
18. McGuire W, Anthony MY. Donor human milk vs formula for preventing necrotising enterocolitis in preterm infants: systematic review. Arch Dis Child Fetal Neonatal Ed 2003;88:F11-F14. (Pubitemid 36084201)
19. Meinzen-Derr J, Poindexter B, Wrage L, et al. Role of human milk in extremely low birth weight infants' risk of necrotizing enterocolitis or death. J Perinatol 2009;29:57-62.
20. Sisk PM, Lovelady CA, Dillard RG, et al. Early human milk feeding is associated with a lower risk of necrotizing enterocolitis in very low birth weight infants. J Perinatol 2007;27:428-433. (Pubitemid 47028923)
21. Stout G, Lambert DK, Baer VL, et al. Necrotizing enterocolitis during the first week of life: a multicentered case-control and cohort comparison study. J Perinatol 2008;28:556-560.
22. Sullivan S, Schanler RJ, Kim JH, et al. An exclusively human milk-based diet is associated with a lower rate of necrotizing enterocolitis than a diet of human milk and bovine milk-based products. J Pediatr 2010;156:562-567 e561.
23. Schanler RJ, Lau C, Hurst NM, et al. Randomized trial of donor human milk vs preterm formula as substitutes for mothers' own milk in the feeding of extremely premature infants. Pediatrics 2005;116:400-406. (Pubitemid 44161466)
24. Brooks HJ, McConnell MA, Corbett J, et al. Potential prophylactic value of bovine colostrum in necrotizing enterocolitis in neonates: an in vitro study on bacterial attachment, antibody levels and cytokine production. FEMS Immunol Med Microbiol 2006;48:347-354. (Pubitemid 44736573)
25. Claud EC, Savidge T, Walker WA. Modulation of human intestinal epithelial cell IL-8 secretion by human milk factors. Pediatr Res 2003;53:419-425. (Pubitemid 36237396)
26. Caplan MS, Simon D, Jilling T. The role of PAF, TLR, and the inflammatory response in neonatal necrotizing enterocolitis. Semin Pediatr Surg 2005;14:145-151. (Pubitemid 41111600)
27. Furukawa M, Narahara H, Yasuda K, et al. Presence of plateletactivating factor-acetylhydrolase in milk. J Lipid Res 1993;34: 1603-1609.
28. Caplan M. Is EGF the Holy Grail for NEC? J Pediatr 2007;150:329-330.
29. Dvorak B. Milk epidermal growth factor and gut protection. J Pediatr 2010;156(2 Suppl):S31-S35.
30. Nair RR, Warner BB, Warner BW. Role of epidermal growth factor and other growth factors in the prevention of necrotizing enterocolitis Milk epidermal growth factor and gut protection. Semin Perinatol 2008;32:107-113. (Pubitemid 351381169)
31. Warner BW, Warner BB. Role of epidermal growth factor in the pathogenesis of neonatal necrotizing enterocolitis. Semin Pediatr Surg 2005;14:175-180. (Pubitemid 41111604)
32. Dvorak B, Khailova L, Clark JA, et al. Comparison of epidermal growth factor and heparin-binding epidermal growth factor-like growth factor for prevention of experimental necrotizing enterocolitis. J Pediatr Gastroenterol Nutr 2008;47:11-18.
33. Feng J, El-Assal ON, Besner GE. Heparin-binding epidermal growth factor-like growth factor decreases the incidence of necrotizing enterocolitis in neonatal rats. J Pediatr Surg 2006;41:144-149. (Pubitemid 43067508)
34. Radulescu A, Yu X, Orvets ND, et al. Deletion of the heparin-binding epidermal growth factor-like growth factor gene increases susceptibility to necrotizing enterocolitis. J Pediatr Surg 2010;4: 729-734.
35. Radulescu A, Zorko NA, Yu X, et al. Preclinical neonatal rat studies of heparin-binding EGF-like growth factor in protection of the intestines from necrotizing enterocolitis. Pediatr Res 2009;65: 437-442.
36. Mohan P, Abrams SA. Oral lactoferrin for the treatment of sepsis and necrotizing enterocolitis in neonates. Cochrane Database Syst Rev 2009; CD007138.
37. Venkatesh MP, Abrams SA. Oral lactoferrin for the prevention of sepsis and necrotizing enterocolitis in preterm infants. Cochrane Database Syst Rev 2010;5:CD007137.
38. Bode L, Rudloff S, Kunz C, et al. Human milk oligosaccharides reduce platelet-neutrophil complex formation leading to a decrease in neutrophil beta 2 integrin expression. J Leukoc Biol 2004;76:820-826. (Pubitemid 39313718)
39. Borst P, Zelcer N, van Helvoort A. ABC transporters in lipid transport. Biochim Biophys Acta 2000;1486:128-144. (Pubitemid 30336797)
40. Ho GT, Moodie FM, Satsangi J. Multidrug resistance 1 gene (Pglycoprotein 170): an important determinant in gastrointestinal disease? Gut 2003;52:759-766.
41. Croop JM, Raymond M, Haber D, et al. The three mouse multidrug resistance (mdr) genes are expressed in a tissue-specific manner in normal mouse tissues. Mol Cell Biol 1989;9:1346-1350. (Pubitemid 19071705)
42. Juliano RL, Ling V. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim Biophys Acta 1976;455:152-162.
43. Sakaeda T, Nakamura T, Okumura K. MDR1 genotype-related pharmacokinetics and pharmacodynamics. Biol Pharm Bull 2002;25:1391-1400. (Pubitemid 39663152)
44. Arias IM, Gatmaitan Z, Mazzanti R, et al. Structure and function of Pglycoprotein in the normal liver and intestine. Princess Takamatsu Symp 1990;21:229-239.
45. Sharma R, Awasthi YC, Yang Y, et al. Energy dependent transport of xenobiotics and its relevance to multidrug resistance. Curr Cancer Drug Targets 2003;3:89-107. (Pubitemid 36389548)
46. Chang XB. A molecular understanding of ATP-dependent solute transport by multidrug resistance-associated protein MRP1. Cancer Metastasis Rev 2007;26:15-37.
47. Musiek ES, Breeding RS, Milne GL, et al. Cyclopentenone isoprostanes are novel bioactive products of lipid oxidation which enhance neurodegeneration. J Neurochem 2006;97:1301-1313. (Pubitemid 43725570)
48. Sakurazawa T, Ohkusa T. Cytotoxicity of organic acids produced by anaerobic intestinal bacteria on cultured epithelial cells. J Gastroenterol 2005;40:600-609. (Pubitemid 41038789)
49. Schiengold M, Schwantes L, Schwartsmann G, et al. Multidrug resistance gene expression during the murine ontogeny. Mech Ageing Dev 2001;122:255-270. (Pubitemid 32322443)
50. Schinkel AH, Mayer U, Wagenaar E, et al. Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) Pglycoproteins. Proc Natl Acad Sci USA 1997;94:4028-4033. (Pubitemid 27180493)
51. Brady JM, Cherrington NJ, Hartley DP, et al. Tissue distribution and chemical induction of multiple drug resistance genes in rats. Drug Metab Dispos 2002;30:838-844. (Pubitemid 34671097)
52. Gutmann H, Hruz P, Zimmermann C, et al. Breast cancer resistance protein and P-glycoprotein expression in patients with newly diagnosed and therapy-refractory ulcerative colitis compared with healthy controls. Digestion 2008;78:154-162.
53. Iizasa H, Genda N, Kitano T, et al. Altered expression and function of Pglycoprotein in dextran sodium sulfate-induced colitis in mice. J Pharm Sci 2003;92:569-576. (Pubitemid 36258971)
54. Buyse M, Radeva G, Bado A, et al. Intestinal inflammation induces adaptation of P-glycoprotein expression and activity. Biochem Pharmacol 2005;69:1745-1754. (Pubitemid 40780074)
55. Panwala CM, Jones JC, Viney JL. A novel model of inflammatory bowel disease: mice deficient for the multiple drug resistance gene, mdr1a, spontaneously develop colitis. J Immunol 1998;161: 5733-5744. (Pubitemid 28519142)
56. Maggio-Price L, Bielefeldt-Ohmann H, Treuting P, et al. Dual infection with Helicobacter bilis and Helicobacter hepaticus in p-glycoproteindeficient mdr1a-/- mice results in colitis that progresses to dysplasia. Am J Pathol 2005;166:1793-1806. (Pubitemid 40734402)
57. Maggio-Price L, Shows D, Waggie K, et al. Helicobacter bilis infection accelerates and H. hepaticus infection delays the development of colitis in multiple drug resistance-deficient (mdr1a-/-) mice. Am J Pathol 2002;160:739-751. (Pubitemid 34160352)
58. Hunter CJ, Petrosyan M, Ford HR, et al. Enterobacter sakazakii: an emerging pathogen in infants and neonates. Surg Infect (Larchmt) 2008;9:533-539.
59. Hunter CJ, Upperman JS, Ford HR, Camerini V. Understanding the susceptibility of the premature infant to necrotizing enterocolitis (NEC). Pediatr Res 2008;63:117-123.
60. Barlow B, Santulli TV. Importance of multiple episodes of hypoxia or cold stress on the development of enterocolitis in an animal model. Surgery 1975;77:687-690.
61. Nadler EP, Dickinson E, Knisely A, et al. Expression of inducible nitric oxide synthase and interleukin-12 in experimental necrotizing enterocolitis. J Surg Res 2000;92:71-77. (Pubitemid 30437462)
62. Jilling T, Simon D, Lu J, et al. The roles of bacteria and TLR4 in rat and murine models of necrotizing enterocolitis. J Immunol 2006;177: 3273-3282. (Pubitemid 44277847)
63. Luckey TD, Mende TJ, Pleasants J. The physical and chemical characterization of rat's milk. J Nutr 1954;54:345-359.
64. Lincke CR, van der Bliek AM, Schuurhuis GJ, et al. Multidrug resistance phenotype of human BRO melanoma cells transfected with a wild-type human mdr1 complementary DNA. Cancer Res 1990;50:1779-1785. (Pubitemid 20098820)
65. Hunter CJ, Singamsetty VK, Chokshi NK, et al. Enterobacter sakazakii enhances epithelial cell injury by inducing apoptosis in a rat model of necrotizing enterocolitis. J Infect Dis 2008;198:586-593.
66. Hunter CJ, Williams M, Petrosyan M, et al. Lactobacillus bulgaricus prevents intestinal epithelial cell injury caused by Enterobacter sakazakii-induced nitric oxide both in vitro and in the newborn rat model of necrotizing enterocolitis. Infect Immun 2009;77:1031-1043.
67. Resta-Lenert S, Smitham J, Barrett KE. Epithelial dysfunction associated with the development of colitis in conventionally housed mdr1a-/- mice. Am J Physiol Gastrointest Liver Physiol 2005;289:G153-G162. (Pubitemid 40944234)
68. Guner YS, Kiela PR, Xu H, et al. Differential regulation of renal sodiumphosphate transporter by glucocorticoids during rat ontogeny. Am J Physiol 1999;277(5 Part 1):C884-C890.
69. McCleary MJ. Epidermal growth factor: an important constituent of human milk. J Hum Lact 1991;7:123-128.
70. Sullivan PB, Lewindon PJ, Cheng C, et al. Intestinal mucosa remodeling by recombinant human epidermal growth factor(1-48) in neonates with severe necrotizing enterocolitis. J Pediatr Surg 2007;42:462-469. (Pubitemid 46335706)
71. Arseni A, Malamou-Ladas E, Koutsia C, et al. Outbreak of colonization of neonates with Enterobacter sakazakii. J Hosp Infect 1987;9:143-150. (Pubitemid 17032503)
72. Clark NC, Hill BC, O'Hara CM, et al. Epidemiologic typing of Enterobacter sakazakii in two neonatal nosocomial outbreaks. Diagn Microbiol Infect Dis 1990;13:467-472.
73. van Acker J, de Smet F, Muyldermans G, et al. Outbreak of necrotizing enterocolitis associated with Enterobacter sakazakii in powdered milk formula. J Clin Microbiol 2001;39:293-297. (Pubitemid 32059606)
74. Mullane N, Healy B, Meade J, et al. Dissemination of Cronobacter spp. (Enterobacter sakazakii) in a powdered milk protein manufacturing facility. Appl Environ Microbiol 2008;74:5913-5917.
75. Torres-Chavolla E, Ramirez-Cerda E, Gutierrez-Rojo R. Isolation and identification of Enterobacter sakazakii in infant milk formulas. Foodborne Pathog Dis 2007;4:164-168. (Pubitemid 47041355)
76. Ballinger JR, Sheldon KM, Boxen I, et al. Differences between accumulation of 99mTc-MIBI and 201Tl-thallous chloride in tumour cells: role of P-glycoprotein. J Nucl Med 1995;39:122-128.
77. Adlerberth I, Wold AE. Establishment of the gut microbiota in Western infants. Acta Paediatr 2009;98:229-238.
78. Weaver LT, Laker MF, Nelson R. Intestinal permeability in the newborn. Arch Dis Child 1984;59:236-241. (Pubitemid 14160504)
79. Favier CF, Vaughan EE, De Vos WM, Akkermans AD. Molecular monitoring of succession of bacterial communities in human neonates. Appl Environ Microbiol 2002;68:219-226. (Pubitemid 34031183)
80. Tapiainen T, Ylitalo S, Eerola E, Uhari M. Dynamics of gut colonization and source of intestinal flora in healthy newborn infants. APMIS 2006;114:812-817. (Pubitemid 44673234)
81. Mahmood B, Daood MJ, Hart C, et al. Ontogeny of P-glycoprotein in mouse intestine, liver, and kidney. J Investig Med 2001;49: 250-257. (Pubitemid 32463531)
82. Gribar JJ, Ramachandra M, Hrycyna CA, et al. Functional characterization of glycosylation-deficient human P-glycoprotein using a vaccinia virus expression system. J Membr Biol 2000;173: 203-214. (Pubitemid 30100212)